Trial Details
Not RecruitingBasic Information
| Clinical ID | c3187 |
|---|---|
| Identifier | DRKS00004240 |
| Trial Title | Do cutaneous adverse events significantly affect monoclonal antibody based anti-TNF therapies in inflammatory bowel disease patients? A national experience throughout all care levels through the German Inflammatory Bowel Disease Study Group. - GISG SKIN |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | K50.9 K51.9;Crohn disease, unspecified;Ulcerative colitis, unspecified;K50.9;K51.9 |
| Interventions | Group 1: All patients who begin a new anti-TNF therapy for Crohn's disease or ulcerative colitis. |
Participant Information
| Sponsor | ChariCampus Virchow-Klinikum |
|---|---|
| City | - |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | observational |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2016-12-31 |